Multiple sclerosis and uveitis: Clinical characteristics and prognosis

Area of Science:

• Neurology
• Ophthalmology
• Immunology

Background:

• Neurological prognosis in multiple sclerosis (MS) varies by clinical pattern.
• The impact of uveitis on MS neurological prognosis is not well understood.

Purpose of the Study:

• To compare the neurological prognosis and clinical features of MS with uveitis against MS without uveitis.
• To identify factors influencing outcomes in MS-associated uveitis.

Main Methods:

• Retrospective case-control study of 35 MS patients with uveitis and 102 matched MS controls.
• Data extracted from Lyon Cohort Uveitis and EDMUS databases.
• Primary endpoint: change in Expanded Disability Status Scale (EDSS) from baseline to last follow-up.

Main Results:

• MS-associated uveitis patients were more frequently of North African origin (48.6% vs 20.6%).
• Median follow-up was 19 years for uveitis group and 16 years for controls.
• No significant difference in EDSS at last follow-up (3.0 vs 3.0).
• Patients over 32 with MS-associated uveitis had a significantly lower risk of disability progression.

Conclusions:

• MS-associated uveitis is more prevalent in North African individuals and may present with a sarcoidosis-like phenotype.
• MS-associated uveitis is linked to a more favorable neurological outcome in patients older than 32 years.